Milestone Pharmaceuticals

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell MIST and other ETFs, options, and stocks.

About MIST

Milestone Pharmaceuticals, Inc. engages in the development and commercialization of cardiovascular medicines. Its lead product candidate etripamil, is a novel, potent and short-acting calcium channel blocker that is designed as a rapid-onset nasal spray to be self-administered by patients.

CEO

Joseph G. Oliveto

CEOJoseph G. Oliveto

Employees

Employees29

Headquarters

Montréal, Québec

HeadquartersMontréal, Québec

Founded

2003

Founded2003

Employees

Employees29

MIST Key Statistics

Market cap

124.80M

Market cap124.80M

Price-Earnings ratio

—

Price-Earnings ratio—

Dividend yield

—

Dividend yield—

Average volume

271.33K

Average volume271.33K

High today

—

High today—

Low today

—

Low today—

Open price

$3.42

Open price$3.42

Volume

0.00

Volume0.00

52 Week high

$9.85

52 Week high$9.85

52 Week low

$3.39

52 Week low$3.39

MIST Earnings

-$0.41

-$0.27

-$0.12

$0.02

Q2 FY21

Q3 FY21

Q4 FY21

Q1 FY22

Q2 FY22

Q3 FY22

Q4 FY22

Estimated

— per share

Estimated— per share

Actual

Expected Mar 23, Pre-Market

ActualExpected Mar 23, Pre-Market